background
develop
innat
adapt
immun
respons
porcin
reproduct
respiratori
syndrom
viru
prrsv
vaccin
dayold
pig
base
modifi
live
viru
mlv
vaccin
intramuscular
im
intranas
rout
characteris
challeng
heterolog
isol
week
postvaccin
twentyf
prrsvseroneg
piglet
use
day
age
pig
administ
singl
dose
vaccin
via
im
n
rout
n
control
group
n
receiv
salin
solut
vaccin
pig
bled
day
level
cytokin
measur
elisa
test
serum
measur
elisa
elispot
respect
stimul
peripher
blood
mononuclear
cell
serum
neutralis
antibodi
na
vaccin
strain
measur
induct
rare
indic
mediat
immunomodulationimmun
dysfunct
featur
vaccin
challeng
viru
detect
two
pig
follow
vaccin
major
pig
challeng
indic
abil
produc
innat
immun
respons
impair
detect
vaccin
pig
day
challeng
minor
pig
produc
detect
vaccin
pig
follow
vaccin
indic
potenti
develop
effect
adapt
immun
respons
cell
detect
vaccin
pig
vaccin
na
vaccin
strain
first
detect
day
pig
vaccin
rout
remain
similar
level
challeng
challeng
boost
na
observ
efficaci
vaccin
demonstr
reduct
viraemia
nasal
shed
challeng
administr
base
mlv
vaccin
dayold
piglet
abl
induc
immun
respons
characteris
undetect
low
level
increas
express
within
first
seven
day
gradual
increas
number
antigenspecif
cell
induct
detect
na
challeng
heterolog
strain
rapid
boost
na
titr
indic
prime
effect
vaccin
develop
adapt
immun
respons
porcin
reproduct
respiratori
syndrom
viru
prrsv
depend
humor
cellular
compon
innat
immun
system
first
mechan
defenc
prevent
viral
invas
replic
influenc
adapt
respons
immun
system
adequ
earli
activ
innat
immun
system
critic
initi
gener
protect
adapt
immun
achiev
complet
viral
clearanc
howev
prrsv
induc
slow
weak
innat
respons
quantiti
import
cytokin
secret
pig
infect
prrsv
like
appear
significantli
lower
pig
infect
influenza
viru
porcin
respiratori
coronaviru
develop
neutralis
antibodi
na
also
known
occur
later
cours
infect
although
nonneutralis
antibodi
appear
day
postinocul
way
humor
cellmedi
specif
immun
delay
compromis
clearanc
viru
serum
na
also
play
import
role
protect
anim
clinic
diseas
passiv
transfer
na
pregnant
sow
titr
protect
reproduct
failur
block
transplacent
infect
use
antibodi
transfer
system
titr
higher
protect
piglet
develop
viraemia
sterilis
immun
obtain
titr
result
suggest
vaccin
capabl
induc
na
titr
given
prrsv
strain
prevent
clinic
diseas
produc
could
import
tool
control
prrsv
taken
account
howev
studi
use
homolog
challeng
model
despit
signific
role
na
seem
play
protect
effect
might
limit
heterolog
isol
demonstr
limit
abil
prrsv
hyperimmun
sera
effect
neutralis
varieti
heterolog
strain
natur
protect
induc
prrsv
mlv
vaccin
heterolog
challeng
controversi
although
wide
accept
heterolog
protect
rather
limit
strain
depend
contrast
model
immun
respons
propos
differ
prrsv
strain
one
base
develop
na
low
respons
base
effect
respons
poor
develop
na
taken
togeth
highli
recommend
defin
profil
humor
cellmedi
immun
induc
given
mlv
vaccin
order
predict
abil
provid
strong
protect
front
challeng
heterolog
strain
abil
immun
system
fight
infecti
agent
condit
suffici
degre
function
matur
immun
system
demonstr
abil
monocyt
neutrophil
young
pig
produc
proinflammatori
cytokin
reduc
compar
adult
pig
pronounc
chang
cytokin
product
occur
wean
therefor
expect
abil
immun
system
prewean
pig
respond
mlv
vaccin
could
reduc
rel
older
anim
object
studi
defin
profil
develop
innat
adapt
immun
prrsv
vaccin
pig
base
mlv
vaccin
suvaxyn
prr
mlv
challeng
virul
heterolog
field
isol
one
day
old
piglet
select
repres
worsecas
scenario
youngest
pig
allow
indic
vaccin
use
two
rout
vaccin
administr
intramuscular
im
intranas
evalu
challeng
delay
week
vaccin
ensur
satisfactori
durat
immun
innat
immun
measur
evalu
level
antiinflammatori
proinflammatori
cytokin
humor
immun
measur
develop
na
cellmedi
immun
evalu
develop
cell
twentyf
piglet
born
prrsvseroneg
sow
use
thu
potenti
impact
matern
deriv
antibodi
assess
studi
anim
alloc
treatment
follow
complet
randomis
design
day
age
two
group
pig
administ
singl
ml
dose
vaccin
via
im
rout
five
pig
control
group
receiv
ml
intramuscular
ml
intranas
salin
solut
vaccin
pig
bled
day
anim
hous
treatment
one
pen
per
treatment
vaccin
phase
prior
challeng
anim
rehous
comingl
one
room
week
postvaccin
day
pig
challeng
isol
level
cytokin
interferonalpha
tumor
necrosi
factoralpha
number
interferongamma
secret
cell
level
na
vaccin
strain
measur
differ
time
point
vaccin
day
challeng
also
prrsv
viraemia
nasal
shed
determin
rtqpcr
day
prior
challeng
day
challeng
ten
day
postchalleng
pig
euthanis
throughout
experiment
period
anim
monitor
daili
clinic
observ
newborn
piglet
use
h
age
commerci
vaccin
suvaxyn
prr
mlv
contain
deriv
field
isol
attenu
serial
passag
cell
engin
express
porcin
prr
receptor
vaccin
use
minimum
immunis
dose
log
ccid
dose
group
day
piglet
inject
im
right
side
neck
piglet
administ
deliv
ml
nostril
piglet
receiv
salin
solut
ml
im
ml
week
postvaccin
day
pig
challeng
isol
dose
ccid
pig
challeng
viru
passag
primari
porcin
alveolar
macrophag
order
ensur
retent
virul
degre
nucleotid
ident
vaccin
viru
challeng
viru
respect
although
virus
belong
subtyp
differ
significantli
sequenc
pig
bled
vaccin
vaccin
pig
bled
day
challeng
day
pig
bled
nasal
swab
taken
day
studi
day
blood
sampl
collect
vaccin
day
challeng
day
test
prrsv
elisa
prr
idexx
follow
manufactur
instruct
blood
collect
appropri
tube
obtain
serum
prrsv
na
assay
prrsv
rtqpcr
cytokin
elisa
test
whole
blood
heparinis
tube
elispot
elisa
nasal
swab
place
ml
pb
cytokin
sera
measur
elisa
use
commerci
pair
monoclon
antibodi
mab
accord
manufactur
instruct
porcin
elisa
kit
thermo
fisher
scientif
cutoff
point
elisa
calcul
mean
od
optic
densiti
neg
control
cytokin
concentr
calcul
use
linear
regress
formula
od
cytokin
standard
provid
manufactur
result
express
pgml
measur
previous
report
day
briefli
plate
coat
antipig
mab
r
system
ugml
sampl
biotinyl
pig
mab
r
system
ad
posit
reaction
reveal
use
streptavidinhorseradish
thermo
fisher
scientif
solubl
tmb
merck
millipor
concentr
calcul
accord
od
obtain
serial
dilut
recombin
porcin
protein
r
system
uml
pbmc
cultur
obtain
heparinis
blood
sampl
densitygradi
centrifug
histopaqu
sigma
measur
respons
pbmc
seed
densiti
cell
per
well
plate
mockstimul
stimul
either
prrsv
vaccin
strain
multipl
infect
moi
mgml
pha
h
incub
cell
cultur
supernat
collect
frozen
use
commerci
elisa
test
porcin
elisa
kit
thermo
fisher
scientif
perform
calcul
prrsvspecif
quantiti
respons
unstimul
well
subtract
respons
virusstimul
well
result
express
pgml
pbmc
use
evalu
frequenc
specif
cell
vaccin
strain
elispot
report
elsewher
elispot
assay
develop
use
commerci
mab
porcin
biotin
bd
bioscienc
pharmingen
pbmc
stimul
prrsv
strain
moi
stimul
vaccin
strain
previous
titrat
express
cell
line
endpoint
limit
dilut
adjust
correspond
moi
prior
conduct
test
unstimul
phastimul
cell
use
neg
posit
control
respect
test
done
quadrupl
reaction
develop
ad
substrat
prrsvspecif
frequenc
calcul
subtract
count
spot
unstimul
well
count
prrsvstimul
well
express
number
respond
cell
pbmc
inactiv
serum
sampl
serial
dilut
twofold
plate
prrsv
strain
vaccin
viru
suspens
contain
ccid
ml
ad
well
plate
incub
h
express
cell
suspens
contain
cellsml
prepar
aliquot
well
new
plate
fifti
microlit
serumviru
mix
transfer
plate
contain
cell
mixtur
incub
co
five
day
direct
immunofluoresc
assay
techniqu
use
fitcconjug
monoclon
antibodi
rural
technolog
inc
perform
na
titr
determin
invers
last
dilut
serum
inhibit
fa
signal
rna
purifi
serum
nasal
swab
sampl
use
biosprint
dna
blood
kit
viraemia
measur
mean
revers
transcript
rt
qpcr
brief
purifi
viral
rna
use
templat
revers
transcrib
min
denatur
min
pcr
program
reaction
consist
cycl
denatur
anneal
qrtpcr
conduct
realtim
pcr
system
thermal
cycler
oligonucleotid
primer
duallabel
probe
use
amplif
forward
final
concentr
revers
final
concentr
duallabel
probe
final
concentr
correspond
base
pair
posit
respect
eu
prototyp
strain
lelystad
genbank
access
number
amplicon
consist
fragment
genom
equival
rna
copi
number
per
interpol
rna
standard
curv
assay
adjust
rna
copi
number
per
ml
sampl
accord
sampl
dilut
data
summari
analys
perform
centralis
data
manag
system
sasstat
user
guid
version
higher
sa
institut
cari
nc
postchalleng
data
anim
comingl
analys
prechalleng
data
summaris
descript
statist
sinc
experiment
unit
pen
replic
postchalleng
data
analys
sinc
anim
commingl
experiment
unit
individu
anim
prior
statist
analysi
result
transform
necessari
use
appropri
logarithm
transform
test
singl
result
move
challeng
hous
transform
data
analys
use
gener
linear
mix
model
fix
effect
treatment
test
multipl
result
move
challeng
hous
transform
data
analys
use
gener
linear
repeat
measur
mix
model
fix
effect
treatment
time
point
treatment
time
point
interact
random
effect
anim
within
treatment
anim
term
prior
statist
analysi
rtqpcr
transform
use
appropri
logarithm
transform
transform
data
analys
use
gener
linear
repeat
measur
mix
model
pairwis
treatment
comparison
made
time
point
treatment
treatment
time
point
interact
effect
signific
p
treatment
least
squar
mean
confid
interv
backtransform
present
neg
sampl
given
valu
prrsv
rna
copiesml
log
prrsv
rna
copiesml
correspond
half
quantif
limit
techniqu
prrsv
rna
copiesml
viraemia
nasal
shed
analys
gener
linear
repeat
measur
mix
model
logit
link
fix
effect
treatment
time
point
treatment
time
point
interact
random
effect
pen
block
within
pen
anim
within
block
pen
treatment
anim
term
linear
combin
paramet
estim
use
priori
contrast
test
signific
p
treatment
effect
treatment
time
point
interact
comparison
made
treatment
time
point
level
signific
p
use
assess
statist
differ
least
squar
mean
back
transform
standard
error
confid
interv
mean
calcul
treatment
time
point
model
converg
fisher
exact
use
analysi
eight
week
vaccin
infecti
urinari
process
characteris
cystiti
urinari
bladder
ruptur
periton
occur
pig
alloc
vaccin
group
one
pig
two
pig
die
pig
treat
enrofloxacin
mgkg
im
anoth
pig
belong
die
bleed
process
rest
pig
remain
healthi
postvaccin
period
challeng
clinic
sign
associ
prrsv
infect
observ
pig
treatment
group
pig
nonviraem
vaccin
challeng
challeng
control
anim
becam
viraem
day
day
challeng
coincid
peak
viraemia
length
viraemia
least
day
sinc
control
pig
still
viraem
end
studi
pig
vaccin
im
rout
viraemia
detect
pig
pig
detect
throughout
postchalleng
period
peak
viraemia
also
day
challeng
although
viru
load
log
lower
control
pig
tabl
end
studi
day
challeng
im
vaccin
pig
one
alreadi
clear
viru
blood
pig
vaccin
rout
viraemia
detect
least
one
time
point
anim
postchalleng
period
peak
viraemia
also
day
challeng
although
viru
load
log
lower
control
pig
tabl
end
studi
day
challeng
vaccin
pig
two
alreadi
clear
viru
blood
viral
load
tabl
significantli
lower
im
vaccin
control
pig
day
challeng
also
viral
load
significantli
lower
vaccin
control
pig
day
challeng
percentag
pig
viraem
significantli
lower
day
p
p
challeng
im
vaccin
group
compar
nonvaccin
pig
viral
load
detect
nasal
swab
tabl
significantli
lower
im
vaccin
control
pig
day
challeng
viral
load
significantli
lower
vaccin
control
pig
challeng
tabl
percentag
shed
pig
significantli
lower
im
vaccin
group
compar
control
group
day
challeng
signific
differ
detect
vaccin
group
control
group
vaccin
group
cell
mediat
immun
measur
vaccin
day
day
challeng
day
tabl
fig
control
pig
produc
measur
vaccin
phase
challeng
detect
one
control
pig
pig
vaccin
im
rout
produc
vaccin
challeng
detect
one
pig
pig
vaccin
rout
produc
pig
vaccin
day
howev
detect
pig
day
challeng
detect
test
pig
differ
level
day
statist
signific
vaccin
control
group
vaccin
group
measur
vaccin
day
day
challeng
day
tabl
fig
control
pig
produc
measur
vaccin
phase
challeng
detect
control
pig
pig
vaccin
im
rout
produc
vaccin
day
howev
produc
pig
day
challeng
detect
pig
pig
vaccin
rout
produc
vaccin
day
howev
produc
pig
day
challeng
detect
pig
differ
level
day
statist
signific
vaccin
control
group
vaccin
group
measur
vaccin
day
tabl
fig
control
pig
produc
measur
vaccin
phase
except
one
pig
low
amount
detect
day
day
detect
control
pig
pig
vaccin
im
rout
produc
pig
day
day
pig
vaccin
rout
produc
pig
day
pig
day
fig
control
pig
produc
measur
vaccin
phase
except
one
pig
low
amount
detect
day
anoth
pig
day
challeng
challeng
detect
pig
pig
vaccin
im
rout
produc
vaccin
except
anim
produc
low
amount
day
challeng
detect
one
pig
pig
vaccin
rout
produc
vaccin
except
anim
day
challeng
detect
one
pig
differ
level
day
statist
signific
vaccin
control
group
vaccin
group
measur
vaccin
phase
day
day
challeng
day
pig
seroneg
prrsv
antibodi
detect
elisa
vaccin
challeng
day
control
pig
remain
seroneg
mean
sp
ratio
vaccin
pig
seroconvert
geometr
mean
antibodi
titr
na
measur
vaccin
phase
day
day
challeng
day
tabl
fig
control
pig
low
undetect
na
titr
throughout
studi
vaccin
pig
develop
level
na
vaccin
challeng
pig
vaccin
im
rout
na
first
detect
day
vaccin
prrsv
known
interact
immun
system
host
modul
immun
respons
infect
prrsv
induc
slow
weak
innat
immun
respons
delay
adapt
immun
respons
object
studi
characteris
develop
innat
humor
cell
mediat
immun
respons
prrsv
vaccin
pig
base
mlv
vaccin
im
rout
challeng
isol
week
postvaccin
level
cytokin
well
level
na
measur
antiinflammatori
cytokin
link
regulatori
cell
activ
decreas
cellmedi
immun
respons
inhibit
induct
proinflammatori
cytokin
hypothesis
strain
prrsv
induct
push
immun
respons
toward
rel
ineffect
induct
specif
respons
studi
induct
detect
level
rare
vaccin
challeng
postvaccin
phase
titr
express
invers
highest
dilut
na
activ
detect
dc
day
challeng
nd
nondetect
limit
detect
techniqu
ns
nonsignific
singl
pig
invaccin
group
show
induct
low
level
pgml
challeng
strain
four
pig
posit
level
pgml
near
absenc
measur
induct
vaccin
viru
indic
vaccin
induc
signific
respons
attribut
regulatori
cytokin
either
period
innat
respons
day
later
stage
trial
mediat
immunomodul
immun
dysfunct
gener
featur
vaccin
strain
demonstr
induct
high
number
posit
featur
vaccin
strain
sinc
relat
inhibit
develop
effect
immun
respons
prrsv
proinflammatori
cytokin
induc
chemotaxi
target
cell
primarili
neutrophil
granulocyt
caus
migrat
toward
site
infect
usual
macrophag
detect
antigen
first
first
cell
releas
recruit
cell
studi
link
respons
enhanc
resist
prrsv
infect
studi
detect
two
pig
follow
vaccin
nonvaccin
group
suggest
vaccin
gener
intens
inflammatori
reaction
young
pig
reduc
abil
produc
respons
immun
stimul
compar
adult
howev
detect
major
vaccin
nonvaccin
pig
challeng
indic
abil
pig
produc
impair
challeng
signific
differ
vaccin
nonvaccin
group
lack
induct
proinflammatori
cytokin
consist
good
safeti
profil
vaccin
system
local
reaction
observ
vaccin
data
shown
involv
system
inflamm
acut
phase
reaction
proinflammatori
cytokin
produc
mainli
activ
macrophag
although
produc
cell
type
endogen
pyrogen
abl
induc
fever
apoptot
cell
death
cachexia
inflamm
enhanc
viral
replic
present
studi
detect
vaccin
pig
challeng
challeng
minor
pig
three
group
produc
detect
level
confirm
inhibitori
effect
prrsv
induct
proinflammatori
cytokin
type
interferon
produc
infect
cell
mediat
first
line
defens
viral
infect
innat
antivir
cytokin
interact
receptor
target
cell
establish
potent
antivir
state
addit
serv
import
link
innat
adapt
immun
enhanc
develop
strong
helper
type
inflammatori
respons
induct
report
weak
absent
prrsv
strain
activ
inhibit
product
inhibit
variou
ifninduc
cellular
gene
product
attribut
specif
viral
protein
implic
primari
caus
impair
immun
respons
viru
studi
detect
vaccin
pig
regardless
rout
level
increas
day
follow
vaccin
remain
low
nonvaccin
control
group
result
would
consist
develop
antivir
respons
consist
induct
secret
shortli
vaccin
indic
potenti
develop
effect
adapt
immun
respons
domin
demonstr
frequenc
respons
viru
well
per
million
type
ii
interferon
proimmun
cytokin
abil
inhibit
viral
replic
directli
import
function
immunomodulatori
primari
cytokin
defin
cell
cell
secret
natur
killer
nk
cell
consid
correl
protect
although
respons
prrsv
infect
pig
appear
delay
consid
weak
compar
swine
virus
aujeszki
diseas
viru
current
studi
detect
vaccin
pig
increas
steadili
number
day
postvaccin
remain
high
challeng
mean
pbmc
im
treatment
respect
confirm
vaccin
posit
modul
gene
express
sustain
secret
cell
restimul
number
nonvaccin
pig
remain
low
mention
proinflammatori
cytokin
induc
prrsv
infect
studi
either
detect
detect
minor
anim
vaccin
howev
innat
adapt
immun
respons
could
clearli
demonstr
follow
vaccin
product
subsequ
develop
induct
vaccin
could
harm
pig
near
absenc
proinflammatori
cytokin
may
contribut
observ
safeti
vaccin
prewean
pig
pig
becam
effect
vaccin
indic
seroconvers
elisa
pig
vaccin
group
level
na
vaccin
expect
rang
prrsv
mlv
vaccin
neutralis
antibodi
vaccin
strain
first
detect
day
pig
vaccin
either
im
rout
sustain
similar
level
challeng
challeng
boost
na
observ
vaccin
group
evid
respons
observ
nonvaccin
group
interestingli
differ
seen
im
vaccin
pig
challeng
day
na
level
significantli
higher
imvaccin
pig
nonvaccin
control
group
day
im
invaccin
group
significantli
higher
control
group
piglet
titr
correl
protect
homolog
reinfect
present
studi
na
titr
prior
challeng
reach
valu
howev
gener
acknowledg
protect
prrsv
infect
mediat
neutral
antibodi
alon
includ
import
cellmedi
compon
studi
almost
complet
clearanc
viraemia
achiev
day
challeng
anim
vaccin
im
rout
anim
detect
level
na
consist
humor
cellmedi
immun
contribut
control
infect
viraemia
nasal
shed
result
confirm
vaccin
protect
pig
use
administr
rout
anim
belong
control
group
still
viraem
day
challeng
contrast
im
vaccin
pig
vaccin
pig
viraem
day
indic
immun
induc
vaccin
abl
clear
challeng
viru
blood
specif
note
anim
high
na
titr
challeng
abl
clear
viraemia
day
even
becom
viraem
one
imvaccin
anim
low
na
titr
challeng
becom
viraem
highest
respons
na
respons
measur
vaccin
strain
result
would
like
differ
lower
heterolog
viru
challeng
viru
use
studi
howev
import
establish
homolog
baselin
perform
vaccin
consid
effect
heterolog
crossreact
immunoassay
abil
vaccin
protect
heterolog
challeng
viru
evid
viraemia
result
magnitud
induct
na
use
homolog
antigen
serv
import
intern
control
futur
studi
challeng
virus
differ
minor
develop
immun
respons
efficaci
vaccin
observ
pig
vaccin
im
rout
sinc
mechan
develop
protect
known
vaccin
interest
tri
rout
administr
could
specul
rout
result
vaccin
viru
replic
develop
system
immun
respons
condit
demonstr
dayold
pig
reduc
abil
respond
immunolog
stimul
compar
pig
wean
age
present
studi
demonstr
piglet
vaccin
day
age
develop
innat
humor
cellmedi
immun
respons
suffici
protect
wild
type
prrsv
challeng
least
week
vaccin
one
explan
appar
contradict
live
natur
vaccin
vaccin
viru
activ
replic
week
follow
vaccin
without
caus
diseas
allow
time
immun
system
neonat
pig
reach
greater
level
matur
elimin
vaccin
viru
conclus
administr
base
mlv
piglet
deriv
prrsfree
parent
stock
abl
induc
innat
cell
mediat
humor
immun
respons
characteris
undetect
low
level
vaccin
pig
mean
im
increas
express
within
first
day
observ
vaccin
pig
gradual
increas
number
antigenspecif
near
zero
pbmc
day
postvaccin
challeng
observ
vaccin
pig
induct
detect
na
vaccin
pig
day
challeng
heterolog
field
strain
rapid
boost
na
titr
observ
nonvaccin
control
group
indic
prime
effect
vaccin
administr
base
mlv
piglet
abl
induc
innat
cell
mediat
humor
immun
respons
characteris
undetect
level
seven
im
increas
express
gradual
increas
na
induct
challeng
heterolog
wild
type
strain
cellular
immun
respons
mediat
humor
immun
respons
elicit
na
abl
prevent
reduc
replic
challeng
viru
allow
faster
clearanc
viraemia
